ArticleFrontiers in neuroscience2025
Validation of Neuphony 8-channel EEG flex cap: a comparative study with BioSemi 64-channel EEG system.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Electroencephalography (EEG) is a widely used tool in neurological assessment and cognitive research due to its reliability, high temporal resolution, and non-invasive nature. While portable EEG systems offer improved accessibility, many rely on electrode caps or extensive electrode arrays, which limit ease of use and portability in applied settings. The present study aimed to evaluate whether the 8-channel wearable Neuphony EEG flex cap can reliably capture key event-related potential (ERP) components such as P300 and mismatch negativity (MMN), while also providing robust measures of continuous EEG activity. Methods: This study involved 25 healthy participants, with an average age of 19.72 ± 0.8 years. EEG recordings were obtained using the Neuphony Flex Cap and BioSemi system while subjects engaged in the following tasks: resting state, auditory oddball, and visual discrimination tasks. Participants were instructed to keep their eyes open and concentrate on a cross during the resting state recording. Two distinct sound tones were played during the auditory oddball task to elicit P300 and MMN responses. For the visual discrimination task, participants were asked to respond upon seeing either an M or a W among distractors. Accuracy and reaction times were recorded for both tasks. Results: We evaluated the average relative PSD of the Neuphony EEG flex cap and BioSemi Active Two system across the entire frequency range (1-30 Hz), revealing a significant difference in the 8 to 13 Hz band. A repeated measures ANOVA showed a significant main effect of device for P300 amplitude [ Discussion: This research indicated that it is feasible to obtain fair-quality EEG data for research purposes using the Neuphony EEG flex cap. However, the strength of the frequency band between 8 and 13 Hz showed variability, as did the event-related peaks. Event-related potentials (ERPs) were comparable for both devices, with a slight consistent delay in the 8-channel Neuphony EEG flex cap, potentially due to Bluetooth signal transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.